Nano-hydroxyapatite and bleaching sensitivity: the paste trial read closely, and what the other trials tested.

The nano-hydroxyapatite bleaching trials tested three different things, and none of them was a toothpaste started after a course of bleaching: a paste used straight after each bleaching application, a solution put on by the dentist before in-office bleaching, and mineral mixed into the bleaching gel¹⁵². In the paste trial quoted most often, 42 people bleaching at home had fewer days of sensitivity with the paste (36 against 76, p = 0.001), but the drop in how many of them felt any, from 51% to 29%, was not statistically significant (p = 0.06)¹. The clearer positive results came from what a dentist applies: 2% nano-hydroxyapatite mixed into a 6% hydrogen peroxide gel lowered sensitivity in a randomised trial of 60 people². A nano-hydroxyapatite solution painted on before in-office bleaching did the same in a randomised trial of 64⁵. Pooled across 22 randomised trials, calcium-containing desensitisers did not lower the risk of bleaching sensitivity (risk ratio 0.95, 95% CI 0.90 to 1.01, low certainty), and lowered its intensity by about one point on a ten-point scale at very low certainty³. S3 Sensitivity Science™ declares nano-hydroxyapatite at 10% as supplied, with a lower active content, in rod-shaped crystals under 100 nm; no bleaching trial used S3, and no trial has tested any hydroxyapatite toothpaste started after a bleaching course.

What was checked20 peer-reviewed studies and reviews, the NHS and the Oral Health Foundation

What did the 2012 paste trial set out to test?

It asked whether a nano-hydroxyapatite paste, put on straight after each application of a home bleaching gel, would cut the sensitivity that the bleaching brings on¹. The authors started from two ideas stated in their abstract: that defects in enamel make bleaching sensitivity easier to set off, and that a nano-hydroxyapatite paste had already been shown to repair such defects. The trial tested the consequence rather than the ideas. If the paste works, the people using it should hurt less.

Forty-two people were randomised to the paste or to a placebo paste with no hydroxyapatite in it, and bleached at home with a 7% hydrogen peroxide gel twice a day for 14 days, using their assigned paste for five minutes immediately after each application¹. They kept a daily diary for four weeks. The trial was published in 2012, and of everything on this page it is the design closest to the question most readers bring: a paste, used by the person, around a home course¹.

This page read it from its abstract and its PubMed record. The full text could not be opened from the publisher in September 2026 and the paper is not in PubMed Central, so the details that live only in its methods section are marked as missing in the table below rather than guessed. The paste was a commercial product from a Japanese maker; the abstract names it, and this page refers to it by its active ingredient. PubMed lists non-US government research support and carries no conflict-of-interest statement¹. The journal ran a short commentary on the trial in the same issue, which has no abstract and was not read.

How was it done?

As a small placebo-controlled trial whose abstract answers some of the questions a reader would ask and leaves others open¹. The right-hand column holds only what the abstract and the PubMed record state.

Two cells in that table change how the result reads. The abstract does not say which of the three sensitivity measures was the primary outcome, so a reader cannot tell from it whether the one that reached significance was the one the trial was designed around¹. And the day counts, 76 and 36, can only be totals across each group, because a per-person figure that high would not fit inside a four-week diary; the abstract gives neither the group sizes nor how those days were spread between people¹. A total of days can move a long way if two or three people have long runs of pain, and nothing in the record shows whether that happened.

What did it find, measure by measure?

One significant result from three sensitivity measures, and it was the count of days¹.

How many people had any sensitivity: 51% of the placebo group and 29% of the paste group reported it, a difference with a p value of 0.06¹. By the usual threshold of 0.05 that is not statistically significant¹. It is not nothing either. With 42 people in the trial, a gap of that size could be a real effect the trial was too small to confirm, or it could be chance, and the abstract cannot settle which¹.

How many days: 76 days of sensitivity in the placebo group against 36 in the paste group, with a p value of 0.001¹.

How bad it was: the change in intensity on the visual analogue scale leaned towards the placebo group faring worse, without reaching significance (p = 0.16)¹.

Colour: the shade change was equivalent in the two groups, so the paste did not blunt the bleaching¹.

The authors confined their conclusion to the number of days of sensitivity during active bleaching¹. A shorter spell is worth something to a person halfway through a course. It is also a narrower finding than "nano-hydroxyapatite stops bleaching sensitivity", which is how the trial tends to travel, and the pooled evidence further down does not rescue the broader version¹³.

What did the other nano-hydroxyapatite and calcium trials test?

Six randomised trials in people have tested hydroxyapatite against bleaching sensitivity, and they placed it in three different spots: in a paste or product used after bleaching, on the teeth before in-office bleaching, and inside the bleaching gel.

The count comes from two PubMed searches run in September 2026 and one reference list. The first search, for hydroxyapatite, nano-hydroxyapatite, nanohydroxyapatite, n-HAp or nHAp with tooth bleaching, dental bleaching or tooth whitening, with sensitivity or hypersensitivity, and with random* or trial, returned nine records, four of them trials in people. A broader search, for hydroxyapatite, nanohydroxyapatite, nano-hydroxyapatite or calcium phosphate with bleaching or whitening and sensitivity or hypersensitivity, returned fifty-three records and added a fifth, a trial whose title speaks of bleached enamel rather than bleaching. The reference list of the 2023 meta-analysis read below added a sixth, published in a journal that PubMed does not index, and a conference-proceedings paper that is left out of the count because proceedings are not a vetted journal³.

The table sets all of them out by vehicle, beside the calcium-based relatives that the pooled review also covered, and it ends with S3 as a row for orientation only: a daily toothpaste declaring 10% nano-hydroxyapatite and 5% biomimetic hydroxyapatite as solution, 5% potassium nitrate and 1450 ppm fluoride, which no trial has tested.

Pastes and products used after bleaching

Used after each session, the results thin out. In the 2012 randomised trial, the paste shortened the spell without significantly changing how many people had one¹. An experimental 2.5% nano-hydroxyapatite paste, left on for 30 minutes after in-office bleaching with a 40% gel, made no difference on the first or second day compared with no treatment at all, in a randomised trial of 64 adults; from the third day only the untreated group reported any sensitivity⁶. In that same trial a potassium nitrate and fluoride gel did no better on those two days⁶.

A 2018 double-blind trial of 60 people bleaching at home reported less sensitivity with nano-hydroxyapatite than without on the day after the course ended (p = 0.05), and no difference at 30, 60 or 90 days; how the mineral was given is not in the abstract, and three attempts to open the full text failed⁸. It comes from the research group behind a 2017 trial of toothpastes after home bleaching that used the same 22% carbamide peroxide gel, the same 20 people per group and the same air-jet test, and neither abstract says whether any volunteers took part in both⁸²³.

Two small trials with the same senior author used the bleaching tray as the applicator, filling it with a calcium-based paste for half an hour after each home session¹²¹³. With CPP-ACP, 24 people in a double-blind randomised trial reported less sensitivity on day three than people given a placebo paste¹². With a toothpaste containing 5% bioactive glass, 24 volunteers in the second double-blind randomised trial scored lower on average over the week, 0.79 against 1.42 on a ten-point scale (p = 0.013), with the gap significant on the first day and not on the third or sixth¹³. That toothpaste was never brushed, and the trial took only volunteers who had no past trouble with sensitive teeth¹³.

After in-office bleaching with 35% peroxide, a CPP-ACPF paste applied for five minutes after each of three sessions lowered sensitivity after the first session only, and a calcium sodium phosphosilicate paste made no difference, in a double-blind randomised trial that randomised 60 people and analysed 51¹⁰. The paper's discussion credits the phosphosilicate paste with an effect in the first session that its own results table does not show, and this page follows the table¹⁰.

Before in-office bleaching

Put on by the dentist beforehand, the two trials split. A nano-hydroxyapatite solution left on the teeth for four minutes before a single session with a 38% gel gave less sensitivity than a placebo gel or CPP-ACP, and matched a neutral sodium fluoride gel, in a randomised trial of 64 volunteers whose abstract gives no concentration⁵. A nano-calcium phosphate paste that also carried potassium nitrate and fluoride, painted on for ten minutes before each of two sessions with a 35% gel, left the risk where it was: 85% of the paste group and 80% of the placebo group felt sensitivity at least once (p = 1.0)⁴.

That second trial was sized to detect a fall in risk from 83% to 43%, so a smaller benefit could have slipped past it, and it excluded people with gum recession or exposed dentine⁴. The two results test different things rather than contradicting each other outright: one used a hydroxyapatite solution on its own, the other a calcium phosphate paste whose full recipe its authors say the maker did not give them, and those authors wondered whether the calcium phosphate and the potassium nitrate interfered with each other⁵⁴.

Inside the bleaching gel

Mixed into the gel, the mineral has one clearly positive trial and two that are not. In an examiner-blinded randomised trial of 60 people, a 6% hydrogen peroxide gel containing 2% nano-hydroxyapatite gave significantly lower sensitivity during treatment than the same gel without it, bleached just as effectively, and relapsed to a similar degree by nine months; its published summary gives the direction and no numbers².

In a triple-blind split-mouth randomised trial of 54 people, a 35% in-office gel carrying a hydroxyapatite–capsaicin nanocomposite left the risk untouched, with 87 in every hundred feeling discomfort whichever gel was on their teeth, while the intensity was lower at every time point up to 48 hours and the colour change matched⁷. Because the additive paired hydroxyapatite with capsaicin, the trial cannot say how much of that lower intensity belongs to the mineral⁷. And an in-office gel with bioactive nanoparticles, whose composition the abstract does not give, changed neither the risk, 27 in every hundred without and 21 with, nor the intensity, in a triple-blind randomised trial of 66 people⁹.

One clinical study of 80 people added amorphous calcium phosphate before in-office bleaching and to the home gel and reported lower scores, but it does not describe how people were allocated or whether anyone was blinded, its abstract and methods give different concentrations, and its methods list a nano-hydroxyapatite toothpaste among the home instructions without saying which group used it¹¹.

Why do the trials disagree?

Three things in the table explain most of the spread. Where the mineral sits decides how long it touches the tooth: mixed into the gel it stays for the whole application, painted on beforehand it stays for minutes, and as a paste after bleaching it stays for five minutes to half an hour before it is rinsed away²⁵¹⁶. Strong in-office gels leave little room for a difference in who gets sensitivity at all, when 80 to 87 in every hundred feel it without the additive, in the placebo group or on the untreated side of a randomised trial⁴⁷. And the measure matters. Of the five trials in the table that counted how many people had any sensitivity, one reported fewer without printing the numbers², one reported fewer by a margin that missed significance¹, and three found no change⁴⁷⁹. Most of the positive results are about intensity or days, and several come from trials of 24 people¹²¹³.

What does the pooled evidence say?

On whether bleaching sensitivity happens at all, the pooled answer is that calcium-containing desensitisers did not lower the risk³.

The 2023 systematic review and meta-analysis, published in the Journal of the American Dental Association, combined 22 randomised trials of topical calcium-containing desensitisers used with bleaching, most of them at high risk of bias³. The risk of sensitivity was not reduced (risk ratio 0.95, 95% CI 0.90 to 1.01, p = 0.08), at low certainty³. In the meta-analysis the intensity was 0.98 points lower on a ten-point visual analogue scale (95% CI 0.60 to 1.36 points lower), at very low certainty, and the colour change was unaffected³. Put plainly, a risk ratio of 0.95 with an interval reaching 1.01 is compatible with no effect, and a difference of about one point on a ten-point scale is a modest one, graded at the lowest certainty the method allows³. The order matters: the intensity result is the one that sounds like a benefit, and it is the less certain of the two.

Its full text is behind the publisher's paywall, so this page could not see which trials went into each estimate or whether nano-hydroxyapatite was analysed on its own, and the abstract reports no such subgroup³. The review's reference list, public on Crossref, cites the 2012 paste trial, the pre-bleaching solution trial, the null nano-calcium phosphate paste, the 2.5% paste trial and the 2018 home-bleaching trial, and does not cite the 2015 in-gel trial³. Cited is not the same as included, and the one trial with an unambiguous positive result for mineral mixed into the gel may sit outside the pooled number²³.

A 2025 systematic review and meta-analysis asked a narrower question, about calcium-based agents built into the bleaching gel, and reached a warmer conclusion: across 56 studies, 50 of them in vitro and six clinical trials, the agents reduced enamel changes and peroxide diffusion and, in the clinical trials, sensitivity, without weakening the bleaching effect¹⁴. Its agents were calcium ions, calcium gluconate, amorphous calcium phosphate, CPP-ACP and calcium polyphosphate, none of them nano-hydroxyapatite, and its summary does not say how many fewer people had pain¹⁴.

A 2025 scoping review of nanostructured additives in bleaching agents counted 21 articles, 11 of them in vitro and nine clinical, reported mostly favourable results with the strongest for titanium dioxide nanoparticles, and did not pool anything or grade certainty¹⁵. The two meta-analyses point in different directions because they asked different questions, and the one that asked about risk across calcium-based agents, from trials in people rather than laboratory samples, is the one that found no reduction³¹⁴.

Is the nano-hydroxyapatite in S3 the kind these trials tested?

No: the declared form and the tested forms barely overlap. S3 declares its nano-hydroxyapatite at 10% as supplied and states that the active hydroxyapatite content is lower than that inclusion figure. The particles are declared under 100 nm, rod-shaped and crystalline, sized for the dentine tubule, with a less crystalline biomimetic hydroxyapatite of around two microns beside them for the surface. The same tube carries 5% potassium nitrate and 1450 ppm fluoride, and it is a daily toothpaste that is brushed and spat out.

Against that, there is little to line up. Nano-hydroxyapatite has been tested at concentrations between 5% and 15% in remineralisation and sensitivity studies; the two bleaching trials that state a concentration used less, 2% inside a peroxide gel and 2.5% in an experimental paste left on for 30 minutes²⁶. The 2012 paste, the pre-bleaching solution and the 2018 home-bleaching trial give no concentration in their abstracts, and none of the six abstracts gives a particle shape¹⁵⁸. The 2025 randomised trial's gel used hydroxyapatite bound into a composite with capsaicin⁷.

So the nearest thing to S3's declared form in this literature is not near: the concentrations that are stated are lower, the particle shapes are not stated, and the vehicles are a gel, a solution and pastes left on the teeth, not a toothpaste used twice a day. No bleaching trial has used S3, before, during or after a course, and nothing on this page suggests that its nano-hydroxyapatite reduces, prevents or shortens bleaching sensitivity. The clearest single trial result for nano-hydroxyapatite came from mineral mixed into a dentist's bleaching gel, and S3 is a toothpaste that no bleaching trial has tested².

What nano-hydroxyapatite is designed to do in everyday sensitive teeth, a different condition from bleaching pain, is covered on the pages on how nano-hydroxyapatite seals dentine tubules and whether nano-hydroxyapatite toothpaste works for sensitive teeth.

Does hydroxyapatite change tooth colour as well?

Not in a way that interferes with bleaching, in the trials that checked. The 2012 paste, the 2015 in-gel mineral, the 2018 home-bleaching trial and the 2025 composite gel all left the colour change level with their comparison groups¹²⁸⁷. One trial went the other way: after in-office bleaching, teeth given the experimental 2.5% nano-hydroxyapatite paste moved further on the shade guide than teeth given the potassium nitrate gel⁶.

Hydroxyapatite pastes are also marketed as whiteners in their own right, which is a separate question from bleaching sensitivity. A 2023 systematic review, two of whose three authors are employees of a German company that makes hydroxyapatite toothpastes, gathered 17 studies, 13 of them in vitro and four reports covering six preliminary clinical trials, and concluded that hydroxyapatite products lightened enamel, while calling the clinical evidence modest¹⁷. That describes mineral deposited on the enamel surface, not bleaching, and the page on whitening toothpastes and sensitivity covers what surface products can and cannot do.

What does the evidence not show?

The gaps sit where the reader's question sits.

• A toothpaste started after a course. A PubMed search in September 2026 for hydroxyapatite with toothpaste or dentifrice, with after bleaching, post-bleaching, following bleaching or after whitening, and with sensitivity, returned three records, none of them about this question; a wider search without the toothpaste and sensitivity terms returned eighty-one, mostly laboratory work on bleached enamel, with nothing in people. No published trial has tested a hydroxyapatite toothpaste started after a bleaching course; the trials put the mineral in the gel, in a solution beforehand, or in a paste during the course.
• A toothpaste brushed during the course. In the reports this page could read, no nano-hydroxyapatite product was simply brushed on as toothpaste while people bleached: the 2012 abstract does not say how its paste was applied, the 2.5% paste was left on for half an hour, and the one toothpaste in the table, a bioactive glass paste, went into a tray¹⁶¹³. The clinical study that listed a nano-hydroxyapatite toothpaste among its home instructions did not say which group used it, so it tells nothing about that toothpaste¹¹.
• People who already have sensitive teeth. This reader was screened out more than once: exposed dentine or gum recession ruled volunteers out of the nano-calcium phosphate and 2.5% paste trials, and the bioactive glass trial took only volunteers without such a past⁴⁶¹³. How often bleaching trials leave this group out altogether is tallied on the hub page, how to whiten sensitive teeth.
• What sealing tubules would do. In a laboratory study of 30 extracted molars, a stannous fluoride gel, a bioactive glass paste and bioglass air-abrasion each closed more than 99% of the dentine tubules exposed after in-office bleaching, against 26.8% for a laser and 21.6% for a CPP-ACPF paste¹⁶. Nano-hydroxyapatite was not among them, and a tubule closed on a cut section of dentine is a mechanism, not a measure of pain¹⁶. The leading explanation places bleaching pain in the pulp, after peroxide has crossed intact enamel and dentine, which a 2010 hypothesis paper set against the exposed-dentine account of everyday sensitivity²⁰; if that is right, sealing tubules after the event is not obviously the job that needs doing, and the page on why whitening makes teeth sensitive takes that explanation further.
• A dose. No trial has set one concentration of nano-hydroxyapatite against another for bleaching sensitivity.
• Anything lasting. The 2015 gel trial followed colour for nine months; its finding on pain comes from the weeks of bleaching².

What is worth asking the dentist?

Whether the bleaching gel carries a desensitising or calcium additive, because the gel, not a toothpaste bought afterwards, is where the mineral trials put their clearest result². The strength of the gel and how long it stays on are the other levers, and both belong to the dentist. The page on how to whiten sensitive teeth sets out what those levers cost in colour, the page on potassium nitrate before bleaching reads the other ingredient people are told to start early, and the page on using a sensitivity toothpaste alongside a course covers the routine.

The NHS page on teeth whitening, last reviewed in August 2025, lists teeth becoming sensitive to cold or sweet food and drink among the side effects of whitening by a dental professional, and tells people to talk to their dentist about side effects that bother them¹⁸. The Oral Health Foundation's whitening page lists temporary sensitivity, especially to cold¹⁹. Neither page, as read in September 2026, mentions hydroxyapatite. The foundation's page on sensitive teeth names toothpastes containing potassium citrate, potassium nitrate or stannous fluoride for everyday sensitivity and does not mention hydroxyapatite either²².

Bleaching sensitivity rarely lasts long. In a randomised trial that followed 120 adults after in-office bleaching, pain scores were at their highest over the first two days and close to zero by day seven²¹. The Journal's page on sensitive teeth after whitening covers the fortnight after a course, and its page on what dentine tubules are explains the channels that tubule-sealing ingredients are designed for.

Frequently asked questions

Should I use a hydroxyapatite toothpaste after whitening?

Nobody has tested that. No published trial has started a hydroxyapatite toothpaste after a bleaching course; the trials used mineral inside the gel, a solution before in-office bleaching, or pastes left on the teeth during the course. The paste trial nearest to home use shortened the spell of sensitivity without significantly changing how many people had one, and pooled calcium-based desensitisers did not lower the risk¹³. In the trials that measured colour, the bleaching result was unchanged¹². If teeth hurt after a course, the NHS advice is to tell the dentist about side effects that bother you¹⁸.

Does nano-hydroxyapatite in the bleaching gel reduce sensitivity?

In one trial, yes: 2% nano-hydroxyapatite in a 6% hydrogen peroxide gel gave lower sensitivity during treatment in an examiner-blinded randomised trial of 60 people². A newer triple-blind randomised trial of a hydroxyapatite–capsaicin nanocomposite in a 35% gel, in 54 people, lowered the intensity but not the risk, with 87 in every hundred feeling discomfort on either side⁷. A gel with bioactive nanoparticles changed neither in a triple-blind randomised trial of 66 people⁹. Whether the gel has an additive is the dentist's choice, which makes it a question for before the appointment.

Does the nano-hydroxyapatite in S3 reduce sensitivity after bleaching?

No trial has tested S3 in anyone having their teeth bleached; it declares nano-hydroxyapatite at 10% as supplied, with a lower active content, under 100 nm and rod-shaped, in a daily toothpaste. The trials of other preparations found fewer days of sensitivity with a paste used after each home application, and no difference on the first two days with a 2.5% paste after in-office bleaching¹⁶. Pooled across 22 randomised trials, calcium-containing desensitisers did not lower the risk of bleaching sensitivity³.

Is hydroxyapatite better than potassium nitrate for bleaching sensitivity?

No trial answers that well. One small randomised trial put them side by side after in-office bleaching, a 2.5% nano-hydroxyapatite paste against a 3% potassium nitrate and fluoride gel, and on the days people felt sensitivity neither did differently from no treatment⁶. The page on potassium nitrate before bleaching reads the potassium nitrate trials one by one.

Does hydroxyapatite affect the whitening result?

Not in the trials that measured it: the colour change was the same with and without the mineral in the 2012 paste trial, the 2015 in-gel trial and the 2025 composite gel trial¹²⁷. In one trial, teeth given a 2.5% nano-hydroxyapatite paste after in-office bleaching moved further on the shade guide than teeth given a potassium nitrate gel⁶.